PK Study to Assess Drug-drug Interaction and QTc Between Sitravatinib and a Cocktail of Substrates
Phase 1 Completed
40 enrolled
A Drug-drug Interaction Study Of Fluzoparib (SHR3162) on Patients With Recurrent Ovarian Cancer
Phase 1 Completed
33 enrolled
DDI
Phase 1 Completed
17 enrolled
The DDI Study Had Been Designed to Investigate the Effect of SHR3680 on the Pharmacokinetics of Midazolam, S-Warfarin and Omeprazole
Phase 1 Completed
18 enrolled
A Study of Abemaciclib in Participants With Cancer That is Advanced or Has Spread to Another Part(s) of the Body
Phase 1 Completed
48 enrolled 30 charts
A Phase I, Multi-center, Open Label, Drug-drug Interaction Study to Assess the Effect of Ceritinib on the Pharmacokinetics of Warfarin and Midazolam in Patients With ALK-positive Advanced Tumors
Phase 1 Completed
33 enrolled
Warfarin and Vatalanib in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
24 enrolled
A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Pathway of Warfarin
Phase 1 Completed
13 enrolled 17 charts
BAY73-4506 Probe Substrate Study
Phase 1 Completed
41 enrolled
Drug-drug Interaction Study of Tivantinib (ARQ 197) With Omeprazole, S-warfarin, Caffeine, Midazolam, and Digoxin in Cancer Subjects
Phase 1 Completed
28 enrolled
A Study To Test The Effect Of Apatinib On P450 Enzymes
Phase 1 Unknown
20 enrolled
A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
Phase 1 Completed
48 enrolled
Drug-drug Interaction Study With MDV3100 and a Cocktail of Substrates
Phase 1 Completed
14 enrolled
A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies
Phase 1 Completed
27 enrolled